Protecting the Renal System from Sepsis

Sepsis remains a leading cause of mortality in intensive care units across India. Consequently, medical researchers are exploring the SIRT5-PRDX6 axis to find better treatments for sepsis-associated acute kidney injury. A recent study suggests that SIRT5 acts as a critical regulator of cellular survival by modulating ferroptosis. Furthermore, findings reveal that maintaining SIRT5 levels can significantly reduce renal tubular damage during septic episodes.

Pathogenesis of Sepsis-Associated Acute Kidney Injury

During sepsis, the body experiences a systemic inflammatory storm that damages the renal tubules. The study utilized both human HK-2 cells and animal models to examine these pathways. Results showed that SIRT5 levels decrease significantly over time after exposure to lipopolysaccharides. This reduction triggers an increase in pro-ferroptotic markers like ACSL4 and ferrous iron (Fe²⁺). In addition, glutathione (GSH) and GPX4 levels drop, which leaves the kidney vulnerable to oxidative damage.

The SIRT5-PRDX6 Desuccinylation Mechanism

Researchers used co-immunoprecipitation to verify that SIRT5 interacts directly with PRDX6. Specifically, SIRT5 desuccinylates PRDX6 at the lysine 209 (K209) site. Moreover, this specific post-translational modification effectively blocks the inflammatory and oxidative stress responses. Therefore, by maintaining PRDX6 activity, SIRT5 prevents the lipid peroxidation that drives renal cell death. This desuccinylation process serves as a vital defense mechanism against the iron-dependent cell death known as ferroptosis.

Future Therapeutic Directions

In vivo experiments confirmed that SIRT5-deficient mice suffered from aggravated renal injury. In contrast, SIRT5 activation successfully alleviated AKI symptoms and improved survival markers. Consequently, these findings highlight the SIRT5-PRDX6 axis as a promising therapeutic target for patients suffering from sepsis-associated acute kidney injury. Emerging therapies may soon focus on small-molecule SIRT5 activators to protect renal function in critically ill patients.

Frequently Asked Questions

What is the role of SIRT5 in sepsis-associated acute kidney injury?

SIRT5 acts as a protective enzyme that reduces ferroptosis and inflammation by regulating protein succinylation, specifically targeting PRDX6 to maintain renal integrity.

How does desuccinylation at lysine 209 affect PRDX6?

It inhibits lipid peroxidation and mitigates the oxidative stress responsible for renal tubular damage, thereby preventing the progression of sepsis-associated acute kidney injury.

What markers are altered during septic ferroptosis in the kidney?

Key markers include increased ACSL4 and iron levels, along with a significant decrease in GPX4 and glutathione (GSH) levels, which indicates severe oxidative stress.

Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.

References

Lin W et al. Sirtuin 5-mediated desuccinylation of PRDX6 inhibits ferroptosis and alleviates sepsis-associated acute kidney injury. Redox Rep. 2026 Dec 31. doi: 10.1080/13510002.2026.2657075. PMID: 41960638.

Martin-Sanchez D, et al. Ferroptosis: A Potential Therapeutic Target in Acute Kidney Injury. MDPI. 2022.

Li J, et al. Sirtuin 5 alleviates excessive mitochondrial fission via desuccinylation of ATPase inhibitory factor 1 in sepsis-induced acute kidney injury. Shock. 2024.